Discovery of a novel mechanism for the development of colon cancer

	Tweet

Recent work from the Finnish Academy Center of Excellence on Cancer Biology at the University of Helsinki, Finland, has shed light on the mechanisms of colon tumor development and may help to design better treatment for this disease.

Colon cancer is one of the most common malignancies in Western countries: both men and women face a lifetime risk of nearly 6% for the development of invasive colorectal cancer. Epidemiologic studies have shown that several factors contribute to the development of this disease, such as high fat, red-meat diet, obesity and lack of vegetables and fibre in the diet.

In the great majority of cases, colorectal cancer arises from an initially benign overgrowth of colonic lining, a so-called adenomatous polyp (Fig. 1), which acquires with time harmful mutations and transforms into a dangerous colonic carcinoma.

Observational studies suggest that the adenoma-to-carcinoma sequence takes up to 10 years. Although nearly half of Western population may harbor adenomatous polyps by the age of 50, it is estimated that only a few percent of adenomas will progress to cancer.

The study published as an advance online publication of Cancer Cell, describe a mechanism by which harmless colon polyps acquire the ability to form malignant tumors. Researchers from the University of Helsinki discovered that PROX1, a protein that in embryos controls formation of normal organs, such as liver or eye, becomes abnormally overproduced at early stages of carcinoma development. PROX1 allows tumor cells to grow even in the absence of stimulating signals from surrounding normal tissues, which leads to dangerous overgrowth and development of advanced tumors.

Removal of PROX1 from cancer cells reverses their malignant behaviour, suggesting that PROX1 is a promising target for the development of future therapies for colon cancer.

###

The study was led by the Academy of Finland Research Fellow, Dr. Tatiana Petrova and the Academy Professor, Dr. Kari Alitalo, who jointly supervised the work of a graduate student of Helsinki University Antti Nykänen. The research is a result of collaboration between cancer and developmental biologists, pathologists, geneticists and bioinformaticians from Finland, USA, France, UK and Austria.

The research in the laboratories of Dr. Tatiana Petrova and Dr. Kari Alitalo is supported by the Sigrid Jusélius Foundation, the Association for International Cancer Research, the Academy of Finland and Finnish Cancer Organizations.

Contact: Kari Alitalo

358-505-003-572
University of Helsinki

RELATED STORIES:
Genetic ID of Marker in Lymph Nodes May be Linked to Colorectal Cancer Recurrence Risk   High colon cancer risk with diabetes confirmed   Curry-derived Molecules Might be Too Spicy for Colorectal Cancers   Most Adults Don’t Realize Activity Lowers Colon Cancer Risk   Coffee and sodas not tied to colon cancer   CT scans may predict survival in colorectal cancer   Colon cancer risk in women does not seem to be reduced by physical activity   Cocoa could prevent intestinal pathologies such as colon cancer   Black raspberries may prevent colon cancer, study finds   Novel feces analysis may help detect colon cancer   Folate tied to lower colon cancer risk   Compounds in mate tea induce death in colon cancer cells   Regular Screenings and Healthy Living Reduce Colon Cancer Risk   Poor less likely to be screened for colon cancer   Minimally Invasive Surgery Shown Safe and Effective Treatment for Rectal Cancer   Blood test for colon cancer promising: study   Study finds that competency in colonoscopy requires experience with 150 cases or more   UT Southwestern program identifies families at high risk for colorectal cancer   Fish Oil Protects Against Colon Cancer   A new indicator of poor prognosis in node-negative colorectal cancer patients   Low-dose aspirin lowers colon cancer risk: study   Colonoscopy Prep Harder on Women than Men

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]